Ceenu Related Clinical Trials
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Recruiting]
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients [Recruiting]
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients [Recruiting]
Procarbazine and Lomustine in Recurrent Glioblastoma [Recruiting]
Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old [Recruiting]
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme [Completed]
Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) [Recruiting]
A Study in Recurrent Glioblastoma (GB) [Recruiting]
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML [Completed]
Phase III: Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma. [Recruiting]
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour [Recruiting]
A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain [Recruiting]
Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients [Recruiting]
Bevacizumab and Lomustine in Treating Patients With Glioblastoma Multiforme in First Recurrence [Not yet recruiting]
Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults [Recruiting]
Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [Active, not recruiting]
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas [Active, not recruiting]
Enzastaurin Versus Lomustine in Glioblastoma [Active, not recruiting]
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma [Not yet recruiting]
Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma [Active, not recruiting]
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma [Recruiting]
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma [Recruiting]
Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma [Recruiting]
Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors [Recruiting]
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery [Recruiting]
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas [Active, not recruiting]
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma [Active, not recruiting]
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [Active, not recruiting]
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma [Recruiting]
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma [Completed]
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors [Active, not recruiting]
Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma [Active, not recruiting]
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma [Completed]
Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease [Active, not recruiting]
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma [Active, not recruiting]
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma [Recruiting]
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma [Recruiting]
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma [Completed]
Combination Chemotherapy in Treating Children With Progressive Brain Tumors [Completed]
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma [Active, not recruiting]
Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas [Active, not recruiting]
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma [Active, not recruiting]
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas [Active, not recruiting]
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma [Active, not recruiting]
Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC) [Recruiting]
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas [Recruiting]
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma [Recruiting]
Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors [Completed]
Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours [Recruiting]
|
